Bruker to acquire Michrom
Bruker is set to acquire Michrom Bioresources, a Californian company that provides LC instrumentation, accessories and consumables for applications in the life science, chemical and applied markets.
Bruker is set to acquire Michrom Bioresources, a Californian company that provides LC instrumentation, accessories and consumables for applications in the life science, chemical and applied markets.
Commenting on the agreement, Collin D’Silva, president of Bruker’s Chemical and Applied Markets division, said “Michrom’s broad portfolio of novel technologies and high-performance products is highly complementary to our mass spectrometry products. In particular, their new high duty-cycle nanoflow UHPLC platform, along with their LC–MS interface, will provide our customers with significant gains in throughput, sensitivity and robustness for proteomics and other nano and capillary flow LC–MS applications.”
Michrom’s president Kerry Nugent expects the transaction to make Michrom’s products more widely available to global customers seeking these key novel technologies. He commented: “With Bruker’s manufacturing infrastructure and well-developed global distribution channels, we will be able to make greater strides to provide customers with advanced analytical solutions that embody technologies based on our expertise in biochemistry and microfluidics. I am very excited that the significant potential of our new technologies is now closer to being realized by more discerning customers.”
For more information visit www.bruker.com and www.michrom.com
This story originally appeared in The Column. Click here to view that issue.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
